56 assets in Duchenne Muscular Dystrophy

Therapeutic assets addressing Duchenne Muscular Dystrophy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Rag-18 Duchenne Muscular Dystrophy	Peking Union Medical College Hospital	Early P1	C (38)
Spot-03 Duchenne Muscular Dystrophy	Shanghai Siponuoyin Biotechnology Co Ltd	Early P1	C (38)
Gip Duchenne Muscular Dystrophy	University of Copenhagen	N/A	D (30)
Glucagon-Like Peptide Ii Duchenne Muscular Dystrophy	University of Copenhagen	N/A	D (30)
Rituximab Duchenne Muscular Dystrophy	Peking Union Medical College Hospital	N/A	D (30)
Elevidys Duchenne Muscular Dystrophy	Sarepta Therapeutics, Inc.	P4	NR ()

Showing 51 to 56 of 56 assets

PreviousPage 2 of 2Next